Joseph Stringer is an analyst at Needham. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...

Joseph Stringer, an analyst from Needham, maintained the Buy rating on Ionis Pharmaceuticals (IONS – Research Report). The associated price ...

In a report released today, Joseph Stringer from Needham maintained a Hold rating on Lexicon Pharmaceuticals (LXRX – Research Report). The ...

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), raising the price target to $26 from $23. "PHAT is our top pick for 2024", the analyst ...